StonvexLoading…
StonvexCore line items from SRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $147.35M | $160.85M | $861.26M | $656.11M | $445.84M |
Operating Income | Not available | $-8.98M | $-38.61M | $-9.11M | $-5.83M |
Net Income | Not available | $-27.92M | $-102.83M | $-25.93M | $-9.36M |
EPS (Diluted) | $-0.12 | $-1.00 | $-3.70 | $-0.93 | $-0.60 |
Total Assets | Not available | $511.97M | $551.12M | $632.08M | $639.41M |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $70.54M | $53.06M | $53.99M | $49.77M |
Free Cash Flow OCF − CapEx | Not available | $-12.34M | $12.17M | $9.54M | $12.24M |
Shares Outstanding | Not available | 28.24M | 28.02M | 28.02M | 28.00M |